Skip to content
Thursday, November 12, 2026
RoyalMania

The Zimbabwean Government Declines ‘One-Sided’ US Health Aid Deal Due to Information Concerns

Medical funding illustration
The offered US funding was intended for programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has declined a major US healthcare agreement valued at $367m (£272m) over five years over the United States' request for sensitive information.

The decision was revealed after a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa believed the arrangement was "lopsided".

An official representative later explained that the United States was requesting biological samples for research and commercial purposes while was unwilling to share the benefits from any future treatments.

"We must now begin the challenging and unfortunate process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the United States had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has urged further talks to find a agreement acceptable to all parties so the country's vital HIV programme can be sustained.

Wider Implications

This development follows a similar case in Kenya, where a high court suspended a related health funding agreement after concerns were filed about the security of Kenyans' medical information.

Since resuming office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

USAID had overseen assistance for the American government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to enhance transparency and responsibility.

As per reports, Sixteen nations in Africa have so far signed these new agreements, representing over $18.3bn in new funding.

Details of the Rejected Agreement

The funds for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We believe this cooperation might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently on antiretroviral therapy through US-supported initiatives," Tremont commented.

However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".

"Zimbabwe was being asked to provide its biological resources and data over an extended period, with no corresponding promise of access to any medical innovations – like new medicines or tests – that could be developed from that shared data," he stated.

"Effectively, our nation would provide the basic resources for medical research without any certainty that the resulting innovations would be accessible to our citizens should a future pandemic emerge."

National Interest and Global Health

He also pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were upending frameworks already established via the international health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to deal with future global health emergencies.

"This mechanism is intended to ensure that when a nation contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to create them."

Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We welcome continued discussions with our American counterparts on how future co-operation might be structured in a way that respects the sovereignty and interests of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but recommended that negotiations should continue considering a large portion of the country's HIV programmes relied on international support.

"Where technical issues arise, including those involving data governance or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," it added.

The halted deal underscores the complex challenges between receiving crucial foreign assistance and protecting national sovereignty in an ever more interconnected world.

The writer

Matthew Brown

A seasoned journalist specializing in royal affairs with over a decade of experience covering European monarchies.

RoyalMania

Type to search articles.